354) etect rare subclones possibly involved in treatment resistance. |
355) tential to help in prevention, diagnosis, treatment, screening, management, and cont |
356) demics in terms of prevention, diagnosis, treatment, screening, surveillance, resour |
357) may influence the future of brain injury treatment through modulation of neuroinfla |
358) rtially maintained following cessation of treatment through the duration of hypoxic |
359) t least one G allele, despite montelukast treatment, were increased (odds-ratio = 2. |
360) Successful treatments were reported at least in some |
361) italization and occurring during adjuvant treatment when patients are not burdened b |
362) significantly recovered by antiretroviral treatment when we compared 262 ART positiv |
363) mal prehabilitation program before cancer treatment ("prehabilitation" listed in key |
364) 'Universal' access to antiretroviral treatment (ART) has become the global stan |
365) known as to the effect of electric field treatment (EFT) on the lung. |
366) obtained before (pre-injection) and after treatment (i.e., at 2 and 6 months). |
367) als evaluating the effects of psychiatric treatment (n = 3) and probiotic interv |
368) mized to control or high DBI polypharmacy treatment (simvastatin, metoprolol, oxybut |
369) R47H heterozygous tauopathy mice, MK-2206 treatment abolished a tauopathy-dependent |
370) eosinophils in naïve mice within 2 h of treatment, accompanied by an increase in I |
371) rther, to gain traction on prevention and treatment, additional research to identify |
372) SC trastuzumab are equivalent in terms of treatment-emergent adverse events (TEAEs) |
373) nce it makes a compromise between optimal treatment allocation and randomness with s |
374) vitro and in vivo, as compared to either treatment alone. |
375) Further, alcohol treatment also led to the induction of syn |
376) barrier to engaging in HIV prevention and treatment among both HIV-negative and HIV- |
377) s: (a) family disagreements over curative treatment and/or end-of-life care and deci |
378) Conventional treatment approaches, such as surgery, che |
379) and psychosexual adjustment after cancer treatment are needed. |
380) Ambient/room temperature settings in burn treatment areas vary greatly due to a lack |
381) Adherence was assessed by the treatment attendance rates, and maintenanc |
382) uentially allocating patients to the best treatment based on the responses of patien |
383) X5 to be an oncogenic target and a cancer treatment-resistant biomarker, a few studi |
384) eview identified preliminary evidence for treatment-dependent brain changes in adult |
385) way to assess the clinical efficacy of a treatment by combining the results of rand |
386) However, before incorporation into treatment can occur, there is a need for r |
|